Next-generation Sequencing
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Sanger Sequencing
Maxam-Gilbert Sequencing
The Evidence for Evolution
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 5, 2025

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Jeeyon G Rim1,2, Jennifer G Jackman2, Christoph P Hornik2,3
1Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Drug development needs efficient evidence generation to lower costs and improve public health. Leaders convened to realign incentives, making clinical trials faster, more inclusive, and cost-effective for equitable healthcare.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: